← All Investors
JANUX THERAPEUTICS INC
JANX
Holders
4
Combined Value
$28M
Combined Shares
2,017,216
Current Price
$14.15
52W High
$35.34
vs 52W High
−60.0%
Investor Activity
BUYSELLImplied priceClick a quarter to see who traded
Held By
| Investor | Value | % of Portfolio | Avg Buy Price | Gain | Last Activity | As of |
|---|---|---|---|---|---|---|
| Steve Cohen - Point72 | $16M | 0.02% | ~$25.13 | −43.7% | Bought Q1 2026 | Q1 2026 |
| Ken Griffin - Citadel Advisors | $6.2M | 0.00% | ~$28.75 | −50.8% | Sold Q1 2026 | Q1 2026 |
| Israel Englander - Millennium Management | $5.4M | 0.00% | ~$19.28 | −26.6% | Bought Q1 2026 | Q1 2026 |
| Paul Tudor Jones - Tudor Investment | $412K | 0.00% | ~$27.00 | −47.6% | Sold Q1 2026 | Q1 2026 |
Recent Activity
Ownership History
| Period | Holders | Total Shares | Δ Shares | Total Value | Implied Price |
|---|---|---|---|---|---|
| Q1 2026 | 4 | 2,017,216 | −21.4% | $28M | $13.90 |
| Q4 2025 | 4 | 2,566,229 | −6.3% | $35M | $13.80 |
| Q3 2025 | 4 | 2,739,285 | −26.4% | $66M | $24.44 |
| Q2 2025 | 4 | 3,721,537 | +167.3% | $85M | $23.10 |
| Q1 2025 | 5 | 1,392,366 | −35.4% | $37M | $27.00 |
| Q4 2024 | 5 | 2,153,921 | +46.8% | $115M | $53.54 |
| Q3 2024 | 3 | 1,467,567 | −18.8% | $66M | $45.43 |
| Q2 2024 | 5 | 1,808,058 | — | $75M | $41.89 |